OCULAR THERAPEUTIX, INC financial data

Symbol
OCUL on Nasdaq
Location
Bedford, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1100% % -25%
Quick Ratio 7.4% % -7.8%
Debt-to-equity 40% % 5.1%
Return On Equity -72% % -35%
Return On Assets -51% % -33%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 217,691,779 shares
Common Stock, Shares, Outstanding 215,927,600 shares 37%
Entity Public Float $1,604,700,000 USD 51%
Common Stock, Value, Issued $22,000 USD 38%
Weighted Average Number of Shares Outstanding, Basic 187,241,483 shares 18%
Weighted Average Number of Shares Outstanding, Diluted 187,241,483 shares 18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $51,951,000 USD -18%
Research and Development Expense $197,096,000 USD 54%
Selling and Marketing Expense $53,922,000 USD 30%
General and Administrative Expense $64,376,000 USD 6.1%
Costs and Expenses $321,968,000 USD 37%
Operating Income (Loss) $270,017,000 USD -57%
Nonoperating Income (Expense) $4,078,000 USD 133%
Net Income (Loss) Attributable to Parent $265,939,000 USD -37%
Earnings Per Share, Basic -1.42 USD/shares -16%
Earnings Per Share, Diluted -1.42 USD/shares -16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $737,060,000 USD 88%
Accounts Receivable, after Allowance for Credit Loss, Current $30,650,000 USD -5.4%
Inventory, Net $3,564,000 USD 17%
Assets, Current $782,129,000 USD 77%
Property, Plant and Equipment, Net $19,676,000 USD 110%
Operating Lease, Right-of-Use Asset $4,638,000 USD -22%
Assets $808,057,000 USD 76%
Accounts Payable, Current $4,154,000 USD -0.53%
Employee-related Liabilities, Current $17,971,000 USD 26%
Accrued Liabilities, Current $43,835,000 USD 25%
Contract with Customer, Liability, Current $64,000 USD -76%
Liabilities, Current $50,806,000 USD 23%
Contract with Customer, Liability, Noncurrent $14,000,000 USD 0%
Operating Lease, Liability, Noncurrent $2,815,000 USD -47%
Other Liabilities, Noncurrent $887,000 USD 529%
Liabilities $153,747,000 USD 7.8%
Retained Earnings (Accumulated Deficit) $1,157,023,000 USD -30%
Stockholders' Equity Attributable to Parent $654,310,000 USD 107%
Liabilities and Equity $808,057,000 USD 76%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $44,671,000 USD -32%
Net Cash Provided by (Used in) Financing Activities $4,183,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $1,933,000 USD -658%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 215,927,600 shares 37%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $42,421,000 USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $738,674,000 USD 88%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,140,000 USD -83%
Deferred Tax Assets, Valuation Allowance $292,449,000 USD 30%
Deferred Tax Assets, Gross $295,534,000 USD 29%
Operating Lease, Liability $5,632,000 USD -23%
Payments to Acquire Property, Plant, and Equipment $1,933,000 USD 658%
Lessee, Operating Lease, Liability, to be Paid $6,336,000 USD -27%
Property, Plant and Equipment, Gross $47,196,000 USD 43%
Operating Lease, Liability, Current $2,817,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,317,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,269,000 USD 20%
Operating Lease, Weighted Average Discount Rate, Percent 0.1215 pure 2.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $704,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $750,000 USD -66%
Deferred Tax Assets, Operating Loss Carryforwards $189,192,000 USD 41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $750,000 USD -64%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $981,000 USD 6.6%
Deferred Tax Assets, Net of Valuation Allowance $3,085,000 USD -15%
Share-based Payment Arrangement, Expense $43,184,000 USD 30%
Interest Expense $13,621,000 USD 92%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%